SH3BP5 levels indicate ovarian cancer susceptibility to conventional therapies - Jacquie Liggett Fellowship - Hearing the Ovarian Cancer Whisper, Inc. (H.O.W.) Program Grant

SH3BP5 levels indicate ovarian cancer susceptibility to conventional therapies - Jacquie Liggett Fellowship - Hearing the Ovarian Cancer Whisper, Inc. (H.O.W.) Program .

date/time interval

  • July 1, 2014 - June 30, 2015

awarded by

administered by

sponsor award ID

  • Grant#2015-02

contributor